A detailed history of Xtx Topco LTD transactions in Scynexis Inc stock. As of the latest transaction made, Xtx Topco LTD holds 17,111 shares of SCYX stock, worth $17,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,111
Holding current value
$17,282
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.27 - $2.23 $21,730 - $38,157
17,111 New
17,111 $25,000
Q3 2023

Nov 13, 2023

BUY
$1.93 - $3.64 $39,466 - $74,434
20,449 New
20,449 $46,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.